治疗痛风和高尿酸血症新药——非布索坦

被引:17
作者
王宇 [1 ]
贾薇 [2 ]
机构
[1] 吉林四平市中心医院
[2] 沈阳药科大学制药工程学院
关键词
D O I
暂无
中图分类号
R977 [影响生长代谢机能药物];
学科分类号
100710 [药物代谢动力学];
摘要
引用
收藏
页码:1748 / 1750
页数:3
相关论文
共 5 条
[1]
高尿酸血症的研究进展 [J].
蒋光荣 ;
郑恒 ;
邵少慰 .
医学综述, 2008, (11) :1673-1675
[2]
原发性痛风诊治指南(草案).[J]..中华风湿病学杂志.2004, 03
[3]
In vitro drug–drug interaction studies with febuxostat; a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding; identification of metabolic enzymes and cytochrome P450 inhibition.[J].M. Mukoyoshi;S. Nishimura;S. Hoshide;S. Umeda;M. Kanou;K. Taniguchi;H. Muroga.Xenobiotica.2008, 5
[4]
Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs [J].
Khosravan, Reza ;
Wu, Jing-Tao ;
Joseph-Ridge, Nancy ;
Vernillet, Laurent .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (08) :855-866
[5]
The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase [J].
Khosravan, R ;
Grabowski, BA ;
Mayer, MD ;
Wu, JT ;
Joseph-Ridge, N ;
Vernillet, L .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (01) :88-102